<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Although type 1 and type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> are strongly associated with systemic <z:e sem="disease" ids="C1301700" disease_type="Disease or Syndrome" abbrv="">cardiovascular morbidity</z:e>, the relationship with pulmonary <z:e sem="disease" ids="C0042373" disease_type="Disease or Syndrome" abbrv="">vascular disease</z:e> had been almost disregarded until recent epidemiological data revealed that <z:mp ids='MP_0002055'>diabetes</z:mp> might be a risk factor for <z:hpo ids='HP_0002092'>pulmonary hypertension</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>Recent experimental studies suggest that <z:mp ids='MP_0002055'>diabetes</z:mp> induces changes in lung function insufficient to elevate pulmonary pressure </plain></SENT>
<SENT sid="2" pm="."><plain>The aim of this study was to assess the effects of <z:mp ids='MP_0002055'>diabetes</z:mp> on the sensitivity to other risk factors for <z:hpo ids='HP_0002092'>pulmonary hypertension</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain>We therefore analysed the effects of the combination of <z:mp ids='MP_0002055'>diabetes</z:mp> with exposure to moderate <z:mp ids='MP_0005039'>hypoxia</z:mp> on classical markers of <z:hpo ids='HP_0002092'>pulmonary hypertension</z:hpo> </plain></SENT>
<SENT sid="4" pm="."><plain>Control (saline-treated) and diabetic (70 mg kg(-1) <z:chebi fb="1" ids="9288">streptozotocin</z:chebi>-treated) male Wistar-Kyoto rats were followed for 4 weeks and exposed to normoxia or moderate normobaric <z:mp ids='MP_0005039'>hypoxia</z:mp> (14%) for another 2 weeks </plain></SENT>
<SENT sid="5" pm="."><plain><z:mp ids='MP_0005039'>Hypoxia</z:mp>, but not <z:mp ids='MP_0002055'>diabetes</z:mp>, strongly reduced voltage-gated <z:chebi fb="120" ids="26216">potassium</z:chebi> currents, whereas <z:mp ids='MP_0002055'>diabetes</z:mp>, but not <z:mp ids='MP_0005039'>hypoxia</z:mp>, induced pulmonary artery <z:e sem="disease" ids="C0856169" disease_type="Disease or Syndrome" abbrv="">endothelial dysfunction</z:e> </plain></SENT>
<SENT sid="6" pm="."><plain>Both factors independently induced pulmonary vascular remodelling and downregulated the lung bone morphogenetic protein receptor type 2 </plain></SENT>
<SENT sid="7" pm="."><plain>However, <z:mp ids='MP_0002055'>diabetes</z:mp>, but not <z:mp ids='MP_0005039'>hypoxia</z:mp>, induced <z:e sem="disease" ids="C0235896" disease_type="Disease or Syndrome" abbrv="">pulmonary infiltration</z:e> of macrophages, which was markedly increased when both factors were combined </plain></SENT>
<SENT sid="8" pm="."><plain><z:mp ids='MP_0002055'>Diabetes</z:mp> plus <z:mp ids='MP_0005039'>hypoxia</z:mp> induced a modest increase in diastolic and mean pulmonary artery pressure and right ventricular weight, while each of the two factors alone had no significant effect </plain></SENT>
<SENT sid="9" pm="."><plain>The pattern of changes in markers of <z:hpo ids='HP_0002092'>pulmonary hypertension</z:hpo> was different for moderate <z:mp ids='MP_0005039'>hypoxia</z:mp> and <z:mp ids='MP_0002055'>diabetes</z:mp>, with no synergic effect except for macrophage recruitment, and the combination of both factors was required to induce a moderate elevation in pulmonary arterial pressure </plain></SENT>
</text></document>